Documents
Application Sponsors
NDA 201023 | SANOFI AVENTIS US | |
Marketing Status
Application Products
001 | SOLUTION;INTRAVENOUS | 60MG/1.5ML (40MG/ML) | 1 | JEVTANA KIT | CABAZITAXEL |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2010-06-17 | PRIORITY |
LABELING; Labeling | SUPPL | 3 | AP | 2012-10-04 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2013-04-25 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 2013-03-13 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 2013-09-11 | PRIORITY |
LABELING; Labeling | SUPPL | 10 | AP | 2014-03-14 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2014-11-19 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 2014-03-14 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 13 | AP | 2015-01-05 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 14 | AP | 2015-06-11 | PRIORITY |
LABELING; Labeling | SUPPL | 15 | AP | 2015-06-18 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 16 | AP | 2016-05-27 | PRIORITY |
LABELING; Labeling | SUPPL | 17 | AP | 2016-09-12 | STANDARD |
EFFICACY; Efficacy | SUPPL | 19 | AP | 2017-09-14 | STANDARD |
EFFICACY; Efficacy | SUPPL | 20 | AP | 2017-05-17 | PRIORITY |
LABELING; Labeling | SUPPL | 21 | AP | 2018-01-09 | STANDARD |
LABELING; Labeling | SUPPL | 23 | AP | 2020-03-05 | STANDARD |
EFFICACY; Efficacy | SUPPL | 24 | AP | 2020-12-18 | PRIORITY |
LABELING; Labeling | SUPPL | 25 | AP | 2021-02-12 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 6 |
SUPPL | 3 | Null | 7 |
SUPPL | 7 | Null | 15 |
SUPPL | 8 | Null | 0 |
SUPPL | 9 | Null | 0 |
SUPPL | 10 | Null | 6 |
SUPPL | 11 | Null | 6 |
SUPPL | 12 | Null | 6 |
SUPPL | 13 | Null | 0 |
SUPPL | 14 | Null | 0 |
SUPPL | 15 | Null | 15 |
SUPPL | 16 | Null | 0 |
SUPPL | 17 | Null | 15 |
SUPPL | 19 | Null | 7 |
SUPPL | 20 | Null | 8 |
SUPPL | 21 | Null | 6 |
SUPPL | 23 | Null | 15 |
SUPPL | 24 | Null | 6 |
SUPPL | 25 | Null | 15 |
TE Codes
CDER Filings
SANOFI AVENTIS US
cder:Array
(
[0] => Array
(
[ApplNo] => 201023
[companyName] => SANOFI AVENTIS US
[docInserts] => ["",""]
[products] => [{"drugName":"JEVTANA KIT","activeIngredients":"CABAZITAXEL","strength":"60MG\/1.5ML (40MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"03\/05\/2020","submission":"SUPPL-23","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/201023s023lbl.pdf\"}]","notes":""},{"actionDate":"01\/09\/2018","submission":"SUPPL-21","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/201023s021lbl.pdf\"}]","notes":""},{"actionDate":"09\/14\/2017","submission":"SUPPL-19","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/201023s019lbl.pdf\"}]","notes":""},{"actionDate":"05\/17\/2017","submission":"SUPPL-20","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/201023s020lbl.pdf\"}]","notes":""},{"actionDate":"09\/12\/2016","submission":"SUPPL-17","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/201023s017lbl.pdf\"}]","notes":""},{"actionDate":"06\/18\/2015","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/201023s015lbl.pdf\"}]","notes":""},{"actionDate":"11\/19\/2014","submission":"SUPPL-11","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/201023s011lbl.pdf\"}]","notes":""},{"actionDate":"10\/04\/2012","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/201023s003lbl.pdf\"}]","notes":""},{"actionDate":"06\/17\/2010","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/201023lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"06\/17\/2010","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"PRIORITY","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/201023lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2010\\\/201023s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2010\\\/201023s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2010\\\/201023s000SumR.pdf\"}]","notes":">"}]
[supplements] => [{"actionDate":"03\/05\/2020","submission":"SUPPL-23","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/201023s023lbl.pdf\"}]","notes":">"},{"actionDate":"01\/09\/2018","submission":"SUPPL-21","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/201023s021lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/201023Orig1s021ltr.pdf\"}]","notes":">"},{"actionDate":"05\/17\/2017","submission":"SUPPL-20","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/201023s020lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/201023Orig1sS020ltr.pdf\"}]","notes":">"},{"actionDate":"09\/14\/2017","submission":"SUPPL-19","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/201023s019lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/201023Orig1s019ltr.pdf\"}]","notes":">"},{"actionDate":"09\/12\/2016","submission":"SUPPL-17","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/201023s017lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/201023Orig1s017ltr.pdf\"}]","notes":">"},{"actionDate":"05\/27\/2016","submission":"SUPPL-16","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"06\/18\/2015","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/201023s015lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/201023Orig1s015ltr.pdf\"}]","notes":">"},{"actionDate":"06\/11\/2015","submission":"SUPPL-14","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"01\/05\/2015","submission":"SUPPL-13","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"03\/14\/2014","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"11\/19\/2014","submission":"SUPPL-11","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/201023s011lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/201023Orig1s011ltr.pdf\"}]","notes":">"},{"actionDate":"03\/14\/2014","submission":"SUPPL-10","supplementCategories":"Labeling-Patient Package Insert, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"09\/11\/2013","submission":"SUPPL-9","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"03\/13\/2013","submission":"SUPPL-8","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"04\/25\/2013","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2013\\\/201023Orig1s007ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"10\/04\/2012","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/201023s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2012\\\/201023Orig1s003ltr.pdf\"}]","notes":">"}]
[actionDate] => 2020-03-05
)
)